Question:
Understanding the pharmacokinetics of Amikacin is important because it helps clinicians to:
Understanding the pharmacokinetics of Amikacin is important because it helps clinicians to:
Show Hint
Always remember this pharmacological rule: Aminoglycosides rely on Concentration-dependent killing combined with a Post-antibiotic effect, which firmly dictates Once Daily Dosing.
Conversely, Beta-lactam antibiotics rely on Time-dependent killing, which firmly dictates the need for continuous infusions or frequent, multiple daily doses to keep drug levels constantly above the MIC.
Conversely, Beta-lactam antibiotics rely on Time-dependent killing, which firmly dictates the need for continuous infusions or frequent, multiple daily doses to keep drug levels constantly above the MIC.
Updated On: Sep 3, 2026
- Give once daily
- Give twice daily
- Give thrice daily
- Given only in combination
Show Solution
Verified By Collegedunia
The Correct Option is A
Solution and Explanation
Concept:
The question intrinsically relates to how the very specific, unique pharmacokinetic and pharmacodynamic properties of Amikacin (which is a potent aminoglycoside antibiotic) directly influence and dictate its optimal dosing regimen in standard clinical practice.
Understanding the relationship between drug concentration and bacterial killing is essential for maximizing therapeutic efficacy while minimizing severe drug toxicities.
Step-by-step Explanation:
• Amikacin belongs to the aminoglycoside class of broad-spectrum antibiotics, which are utilized primarily in the hospital setting to aggressively treat severe, life-threatening Gram-negative bacterial infections.
• Aminoglycosides exhibit two highly critical and defining pharmacodynamic characteristics: concentration-dependent killing and a significant, prolonged post-antibiotic effect (PAE).
• The concept of concentration-dependent killing means that the drug's rapid bactericidal efficacy is directly and linearly proportional to the peak drug concentration ($C_{max}$) achieved in the patient's bloodstream relative to the Minimum Inhibitory Concentration (MIC) of the target pathogen.
• The post-antibiotic effect (PAE) refers to the highly beneficial phenomenon where there is a sustained, ongoing suppression of bacterial replication and growth even long after the measurable drug concentration in the serum has fallen completely below the therapeutic MIC.
• Precisely because of these unique properties, administering the entire, calculated total daily dose of Amikacin as a single, large, once-daily intravenous infusion maximizes the peak serum concentration, thereby vastly optimizing the initial bacterial killing rate.
• Furthermore, the major, dose-limiting toxicities associated with aminoglycosides (specifically renal nephrotoxicity and irreversible ototoxicity) are strongly and directly associated with sustained, continuously elevated trough levels (which is the lowest measured drug concentration immediately before the next dose is due).
• Giving the drug as a large once-daily dose allows a sufficient amount of time for the circulating drug level to drop and clear to safe, low trough levels before the subsequent dose is given.
• This extended drug-free interval allows the sensitive renal tubular cells to recover, drastically minimizing the overall risk of toxicity.
• Therefore, an understanding of the drug's pharmacokinetic profile unequivocally and scientifically supports the modern clinical standard of extended-interval or once-daily dosing over the outdated, traditional multiple daily dosing methods (Options B and C).
Final Answer:
Understanding the unique pharmacokinetics of Amikacin allows clinicians to safely and effectively administer the drug as a once-daily regimen, maximizing bacterial kill while minimizing renal toxicity.
The question intrinsically relates to how the very specific, unique pharmacokinetic and pharmacodynamic properties of Amikacin (which is a potent aminoglycoside antibiotic) directly influence and dictate its optimal dosing regimen in standard clinical practice.
Understanding the relationship between drug concentration and bacterial killing is essential for maximizing therapeutic efficacy while minimizing severe drug toxicities.
Step-by-step Explanation:
• Amikacin belongs to the aminoglycoside class of broad-spectrum antibiotics, which are utilized primarily in the hospital setting to aggressively treat severe, life-threatening Gram-negative bacterial infections.
• Aminoglycosides exhibit two highly critical and defining pharmacodynamic characteristics: concentration-dependent killing and a significant, prolonged post-antibiotic effect (PAE).
• The concept of concentration-dependent killing means that the drug's rapid bactericidal efficacy is directly and linearly proportional to the peak drug concentration ($C_{max}$) achieved in the patient's bloodstream relative to the Minimum Inhibitory Concentration (MIC) of the target pathogen.
• The post-antibiotic effect (PAE) refers to the highly beneficial phenomenon where there is a sustained, ongoing suppression of bacterial replication and growth even long after the measurable drug concentration in the serum has fallen completely below the therapeutic MIC.
• Precisely because of these unique properties, administering the entire, calculated total daily dose of Amikacin as a single, large, once-daily intravenous infusion maximizes the peak serum concentration, thereby vastly optimizing the initial bacterial killing rate.
• Furthermore, the major, dose-limiting toxicities associated with aminoglycosides (specifically renal nephrotoxicity and irreversible ototoxicity) are strongly and directly associated with sustained, continuously elevated trough levels (which is the lowest measured drug concentration immediately before the next dose is due).
• Giving the drug as a large once-daily dose allows a sufficient amount of time for the circulating drug level to drop and clear to safe, low trough levels before the subsequent dose is given.
• This extended drug-free interval allows the sensitive renal tubular cells to recover, drastically minimizing the overall risk of toxicity.
• Therefore, an understanding of the drug's pharmacokinetic profile unequivocally and scientifically supports the modern clinical standard of extended-interval or once-daily dosing over the outdated, traditional multiple daily dosing methods (Options B and C).
Final Answer:
Understanding the unique pharmacokinetics of Amikacin allows clinicians to safely and effectively administer the drug as a once-daily regimen, maximizing bacterial kill while minimizing renal toxicity.
Was this answer helpful?
0
0
Top NEET SS Medical Questions
- A liver transplant patient presents with diarrhoea, colitis, a total leukocyte count of 1800, and a positive blood CMV PCR. What is the next step in management?
- A 32-year-old male recovering from dengue fever initially showed clinical improvement but now presents with recurrence of high-grade fever, fatigue, and pancytopenia on day 10 of illness. He is hemodynamically stable with no bleeding manifestations. Which of the following investigations should be performed first to evaluate the cause of relapse and cytopenia?
- A 48-year-old man with chronic hepatitis C infection is being evaluated for risk factors associated with progression of liver disease. He has a 20-year history of infection, drinks alcohol occasionally, and has a high serum HCV RNA viral load. Which of the following factors is not associated with an increased risk of progression of liver disease in chronic HCV infection?
- A 28-year-old veterinary worker who previously received a full 3-dose pre-exposure rabies vaccination series is bitten by a stray dog while handling an animal in the clinic. The wound is cleaned immediately. What is the most appropriate post-exposure management?
- A 42-year-old patient undergoing chemotherapy for acute myeloid leukemia develops neutropenia (ANC $<$ 500) and is treated with broad-spectrum antibiotics. After initial recovery of neutrophil counts (ANC = 1500), he again develops high-grade fever and right upper quadrant abdominal pain. Imaging shows multiple small hypodense lesions in the liver and spleen. What is the most likely diagnosis?
View More Questions
Top NEET SS Tropical Medicine Questions
- A 32-year-old male recovering from dengue fever initially showed clinical improvement but now presents with recurrence of high-grade fever, fatigue, and pancytopenia on day 10 of illness. He is hemodynamically stable with no bleeding manifestations. Which of the following investigations should be performed first to evaluate the cause of relapse and cytopenia?
- A 38-year-old HIV-positive man with a CD4 count of 38 presents with fever and generalized tonic-clonic seizures. MRI brain reveals two ring-enhancing subcortical lesions without any specific differentiating features. What is the most likely diagnosis?
- A 28-year-old pregnant woman in her first trimester undergoes routine antenatal evaluation. Urine culture reveals $>$100,000 CFU/mL of E. coli, but she remains asymptomatic. What is the most appropriate next step in management?
- A patient diagnosed with dengue initially improved but later returned with high-grade fever, severe thrombocytopenia (platelet count 15,000), and leukopenia. What is the next best investigation to evaluate the cause?
Top NEET SS Questions
- A liver transplant patient presents with diarrhoea, colitis, a total leukocyte count of 1800, and a positive blood CMV PCR. What is the next step in management?
- A 32-year-old male recovering from dengue fever initially showed clinical improvement but now presents with recurrence of high-grade fever, fatigue, and pancytopenia on day 10 of illness. He is hemodynamically stable with no bleeding manifestations. Which of the following investigations should be performed first to evaluate the cause of relapse and cytopenia?
- A 48-year-old man with chronic hepatitis C infection is being evaluated for risk factors associated with progression of liver disease. He has a 20-year history of infection, drinks alcohol occasionally, and has a high serum HCV RNA viral load. Which of the following factors is not associated with an increased risk of progression of liver disease in chronic HCV infection?
- A 28-year-old veterinary worker who previously received a full 3-dose pre-exposure rabies vaccination series is bitten by a stray dog while handling an animal in the clinic. The wound is cleaned immediately. What is the most appropriate post-exposure management?
- A 42-year-old patient undergoing chemotherapy for acute myeloid leukemia develops neutropenia (ANC $<$ 500) and is treated with broad-spectrum antibiotics. After initial recovery of neutrophil counts (ANC = 1500), he again develops high-grade fever and right upper quadrant abdominal pain. Imaging shows multiple small hypodense lesions in the liver and spleen. What is the most likely diagnosis?
View More Questions